91
Participants
Start Date
September 30, 2000
Primary Completion Date
June 30, 2010
Study Completion Date
February 28, 2011
Valacyclovir
Valacyclovir is a L-valyl ester of acyclovir. Valacyclovir is provided in 500 mg tablets, 4 tablets (500 mg tablets) 3 times a day (every 8 hours) for 90 days.
Placebo
Placebo (identical to active drug in appearance) 500 mg tablets, 4 tablets 3 times daily for 90 days.
Johns Hopkins University, Baltimore
University of Virginia Health System, Charlottesville
University of Toledo, Toledo
Mayo Clinic, Rochester
Northwestern University Feinberg School of Medicine, Chicago
University of Kansas Medical Center, Kansas City
Tulane University Health Sciences Center, New Orleans
University of Colorado, Denver
St. Joseph's Hospital and Medical Center - Barrow Neurological Institute - Phoenix, Phoenix
University of New Mexico, Albuquerque
University of California Davis Medical Center, Sacramento
University of Alabama at Birmingham, Birmingham
Saint Louis University Hospital - School of Medicine - Department of Neurology & Psychiatry, St Louis
University of Manitoba - Medical Microbiology and Infectious Diseases, Winnipeg
Kingston General Hospital - Internal Medicine - Neurology, Kingston
University of Gothenburg - Sahlgrenska Academy, Gothenberg
niversity of Lund - Infectious Disease, Lund
Karolinska University Hospital, Huddinge, Stockholm
Umea University - Infectious Diseases, Umeå
Uppsala University Hospital, Uppsala
University College London - Royal Free Campus - Virology, London
National Institute of Allergy and Infectious Diseases (NIAID)
NIH